Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
New Ray Medicine International Holding Ltd. ( (HK:6108) ) has shared an announcement.
New Ray Medicine International Holding Ltd. has announced a proposed capital reorganization involving share consolidation, capital reduction, and share sub-division. This reorganization aims to consolidate every ten existing shares into one, reduce the par value of shares, and subsequently sub-divide authorized but unissued shares. The reorganization is subject to shareholder approval at a special general meeting, and it may impact the company’s financial structure and shareholder equity.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is a company incorporated in Bermuda with limited liability, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and is involved in the production and distribution of pharmaceutical products.
Average Trading Volume: 3,037,373
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$66.87M
For an in-depth examination of 6108 stock, go to TipRanks’ Stock Analysis page.